ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Covid-19 Treatment Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-28T8961
Home | Market Reports
Global Covid 19 Treatment Market Size Status and Forecast 2022
BUY CHAPTERS

Global Covid-19 Treatment Market Research Report 2026

Code: QYRE-Auto-28T8961
Report
2026-02-27
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
Astrazeneca plc
Cipla Ltd
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline PLC
Gilead Sciences
Pharmstandard
FujiFilm Holdings
Zhejiang Hisun Pharmaceutical Co Ltd
Roche
Sanofi
Pfizer Inc
Eli Lilly

Covid-19 Treatment Market Size

The global Covid-19 Treatment market was valued at US$ 734 million in 2025 and is anticipated to reach US$ 1.56 million by 2032, at a CAGR of -59.3% from 2026 to 2032.

Covid-19 Treatment Market

Covid-19 Treatment Market

Patients today have more treatment options in the battle against coronavirus disease.
In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.
The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.
The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.
In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.
In this report, we study all treatment method for Covid-19.
Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.
This report delivers a comprehensive overview of the global Covid-19 Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Covid-19 Treatment. The Covid-19 Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Covid-19 Treatment market comprehensively. Regional market sizes by Type, by End User, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Covid-19 Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End User, and by region.
Market Segmentation

Scope of Covid-19 Treatment Market Report

Report Metric Details
Report Name Covid-19 Treatment Market
Accounted market size in 2025 US$ 734 million
Forecasted market size in 2032 US$ 1.56 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Life Support
  • Antiviral Medicine
  • Antibody Treatments
  • Others
Segment by End User
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, Ascletis Pharma, GlaxoSmithKline, Gilead Sciences, Pharmstandard, Fujifilm Holdings, Zhejiang Hisun Pharmaceutical Co. Ltd, Roche, Sanofi, Pfizer, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End User, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Covid-19 Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by End User, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

What is the Covid-19 Treatment Market size in 2032?

Ans: The Covid-19 Treatment Market size in 2032 will be US$ 1.56 million.

What is the market share of major companies in Covid-19 Treatment Market?

Ans: The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.

Who are the main players in the Covid-19 Treatment Market report?

Ans: The main players in the Covid-19 Treatment Market are Cadila Healthcare, Johnson & Johnson, ImmunoPrecise, Novartis, AstraZeneca, Cipla, AbbVie, Bayer, Regeneron Pharmaceuticals, Ascletis Pharma, GlaxoSmithKline, Gilead Sciences, Pharmstandard, Fujifilm Holdings, Zhejiang Hisun Pharmaceutical Co. Ltd, Roche, Sanofi, Pfizer, Eli Lilly

What are the Type segmentation covered in the Covid-19 Treatment Market report?

Ans: The Types covered in the Covid-19 Treatment Market report are Life Support, Antiviral Medicine, Antibody Treatments, Others

What are the End User segmentation covered in the Covid-19 Treatment Market report?

Ans: The End users covered in the Covid-19 Treatment Market report are Children, Adult

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Covid-19 Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Life Support
1.2.3 Antiviral Medicine
1.2.4 Antibody Treatments
1.2.5 Others
1.3 Market by End User
1.3.1 Global Covid-19 Treatment Market Growth by End User: 2021 vs 2025 vs 2032
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Covid-19 Treatment Market Perspective (2021–2032)
2.2 Global Covid-19 Treatment Growth Trends by Region
2.2.1 Global Covid-19 Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Covid-19 Treatment Historic Market Size by Region (2021–2026)
2.2.3 Covid-19 Treatment Forecasted Market Size by Region (2027–2032)
2.3 Covid-19 Treatment Market Dynamics
2.3.1 Covid-19 Treatment Industry Trends
2.3.2 Covid-19 Treatment Market Drivers
2.3.3 Covid-19 Treatment Market Challenges
2.3.4 Covid-19 Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Covid-19 Treatment Players by Revenue
3.1.1 Global Top Covid-19 Treatment Players by Revenue (2021–2026)
3.1.2 Global Covid-19 Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Covid-19 Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Covid-19 Treatment Revenue
3.4 Global Covid-19 Treatment Market Concentration Ratio
3.4.1 Global Covid-19 Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Covid-19 Treatment Revenue in 2025
3.5 Global Key Players of Covid-19 Treatment Head Offices and Areas Served
3.6 Global Key Players of Covid-19 Treatment, Products and Applications
3.7 Global Key Players of Covid-19 Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Covid-19 Treatment Breakdown Data by Type
4.1 Global Covid-19 Treatment Historic Market Size by Type (2021–2026)
4.2 Global Covid-19 Treatment Forecasted Market Size by Type (2027–2032)
5 Covid-19 Treatment Breakdown Data by End User
5.1 Global Covid-19 Treatment Historic Market Size by End User (2021–2026)
5.2 Global Covid-19 Treatment Forecasted Market Size by End User (2027–2032)
6 North America
6.1 North America Covid-19 Treatment Market Size (2021–2032)
6.2 North America Covid-19 Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Covid-19 Treatment Market Size by Country (2021–2026)
6.4 North America Covid-19 Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Covid-19 Treatment Market Size (2021–2032)
7.2 Europe Covid-19 Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Covid-19 Treatment Market Size by Country (2021–2026)
7.4 Europe Covid-19 Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Covid-19 Treatment Market Size (2021–2032)
8.2 Asia-Pacific Covid-19 Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Covid-19 Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Covid-19 Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Covid-19 Treatment Market Size (2021–2032)
9.2 Latin America Covid-19 Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Covid-19 Treatment Market Size by Country (2021–2026)
9.4 Latin America Covid-19 Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Covid-19 Treatment Market Size (2021–2032)
10.2 Middle East & Africa Covid-19 Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Covid-19 Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Covid-19 Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Details
11.1.2 Cadila Healthcare Business Overview
11.1.3 Cadila Healthcare Covid-19 Treatment Introduction
11.1.4 Cadila Healthcare Revenue in Covid-19 Treatment Business (2021–2026)
11.1.5 Cadila Healthcare Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Covid-19 Treatment Introduction
11.2.4 Johnson & Johnson Revenue in Covid-19 Treatment Business (2021–2026)
11.2.5 Johnson & Johnson Recent Development
11.3 ImmunoPrecise
11.3.1 ImmunoPrecise Company Details
11.3.2 ImmunoPrecise Business Overview
11.3.3 ImmunoPrecise Covid-19 Treatment Introduction
11.3.4 ImmunoPrecise Revenue in Covid-19 Treatment Business (2021–2026)
11.3.5 ImmunoPrecise Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Covid-19 Treatment Introduction
11.4.4 Novartis Revenue in Covid-19 Treatment Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Covid-19 Treatment Introduction
11.5.4 AstraZeneca Revenue in Covid-19 Treatment Business (2021–2026)
11.5.5 AstraZeneca Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Covid-19 Treatment Introduction
11.6.4 Cipla Revenue in Covid-19 Treatment Business (2021–2026)
11.6.5 Cipla Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Covid-19 Treatment Introduction
11.7.4 AbbVie Revenue in Covid-19 Treatment Business (2021–2026)
11.7.5 AbbVie Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Covid-19 Treatment Introduction
11.8.4 Bayer Revenue in Covid-19 Treatment Business (2021–2026)
11.8.5 Bayer Recent Development
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Details
11.9.2 Regeneron Pharmaceuticals Business Overview
11.9.3 Regeneron Pharmaceuticals Covid-19 Treatment Introduction
11.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (2021–2026)
11.9.5 Regeneron Pharmaceuticals Recent Development
11.10 Ascletis Pharma
11.10.1 Ascletis Pharma Company Details
11.10.2 Ascletis Pharma Business Overview
11.10.3 Ascletis Pharma Covid-19 Treatment Introduction
11.10.4 Ascletis Pharma Revenue in Covid-19 Treatment Business (2021–2026)
11.10.5 Ascletis Pharma Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Covid-19 Treatment Introduction
11.11.4 GlaxoSmithKline Revenue in Covid-19 Treatment Business (2021–2026)
11.11.5 GlaxoSmithKline Recent Development
11.12 Gilead Sciences
11.12.1 Gilead Sciences Company Details
11.12.2 Gilead Sciences Business Overview
11.12.3 Gilead Sciences Covid-19 Treatment Introduction
11.12.4 Gilead Sciences Revenue in Covid-19 Treatment Business (2021–2026)
11.12.5 Gilead Sciences Recent Development
11.13 Pharmstandard
11.13.1 Pharmstandard Company Details
11.13.2 Pharmstandard Business Overview
11.13.3 Pharmstandard Covid-19 Treatment Introduction
11.13.4 Pharmstandard Revenue in Covid-19 Treatment Business (2021–2026)
11.13.5 Pharmstandard Recent Development
11.14 Fujifilm Holdings
11.14.1 Fujifilm Holdings Company Details
11.14.2 Fujifilm Holdings Business Overview
11.14.3 Fujifilm Holdings Covid-19 Treatment Introduction
11.14.4 Fujifilm Holdings Revenue in Covid-19 Treatment Business (2021–2026)
11.14.5 Fujifilm Holdings Recent Development
11.15 Zhejiang Hisun Pharmaceutical Co. Ltd
11.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
11.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
11.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Introduction
11.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (2021–2026)
11.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
11.16 Roche
11.16.1 Roche Company Details
11.16.2 Roche Business Overview
11.16.3 Roche Covid-19 Treatment Introduction
11.16.4 Roche Revenue in Covid-19 Treatment Business (2021–2026)
11.16.5 Roche Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Covid-19 Treatment Introduction
11.17.4 Sanofi Revenue in Covid-19 Treatment Business (2021–2026)
11.17.5 Sanofi Recent Development
11.18 Pfizer
11.18.1 Pfizer Company Details
11.18.2 Pfizer Business Overview
11.18.3 Pfizer Covid-19 Treatment Introduction
11.18.4 Pfizer Revenue in Covid-19 Treatment Business (2021–2026)
11.18.5 Pfizer Recent Development
11.19 Eli Lilly
11.19.1 Eli Lilly Company Details
11.19.2 Eli Lilly Business Overview
11.19.3 Eli Lilly Covid-19 Treatment Introduction
11.19.4 Eli Lilly Revenue in Covid-19 Treatment Business (2021–2026)
11.19.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Cadila Healthcare
Johnson & Johnson
ImmunoPrecise
Novartis
Astrazeneca plc
Cipla Ltd
AbbVie
Bayer
Regeneron Pharmaceuticals
Ascletis Pharma
GlaxoSmithKline PLC
Gilead Sciences
Pharmstandard
FujiFilm Holdings
Zhejiang Hisun Pharmaceutical Co Ltd
Roche
Sanofi
Pfizer Inc
Eli Lilly
List of Tables
 Table 1. Global Covid-19 Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Life Support
 Table 3. Key Players of Antiviral Medicine
 Table 4. Key Players of Antibody Treatments
 Table 5. Key Players of Others
 Table 6. Global Covid-19 Treatment Market Size Growth by End User (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Covid-19 Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Covid-19 Treatment Market Size by Region (US$ Million), 2021–2026
 Table 9. Global Covid-19 Treatment Market Share by Region (2021–2026)
 Table 10. Global Covid-19 Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global Covid-19 Treatment Market Share by Region (2027–2032)
 Table 12. Covid-19 Treatment Market Trends
 Table 13. Covid-19 Treatment Market Drivers
 Table 14. Covid-19 Treatment Market Challenges
 Table 15. Covid-19 Treatment Market Restraints
 Table 16. Global Covid-19 Treatment Revenue by Players (US$ Million), 2021–2026
 Table 17. Global Covid-19 Treatment Market Share by Players (2021–2026)
 Table 18. Global Top Covid-19 Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Covid-19 Treatment Revenue, 2025
 Table 19. Ranking of Global Top Covid-19 Treatment Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by Covid-19 Treatment Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of Covid-19 Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Covid-19 Treatment, Products and Applications
 Table 23. Global Key Players of Covid-19 Treatment, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global Covid-19 Treatment Market Size by Type (US$ Million), 2021–2026
 Table 26. Global Covid-19 Treatment Revenue Market Share by Type (2021–2026)
 Table 27. Global Covid-19 Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global Covid-19 Treatment Revenue Market Share by Type (2027–2032)
 Table 29. Global Covid-19 Treatment Market Size by End User (US$ Million), 2021–2026
 Table 30. Global Covid-19 Treatment Revenue Market Share by End User (2021–2026)
 Table 31. Global Covid-19 Treatment Forecasted Market Size by End User (US$ Million), 2027–2032
 Table 32. Global Covid-19 Treatment Revenue Market Share by End User (2027–2032)
 Table 33. North America Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America Covid-19 Treatment Market Size by Country (US$ Million), 2021–2026
 Table 35. North America Covid-19 Treatment Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe Covid-19 Treatment Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe Covid-19 Treatment Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific Covid-19 Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific Covid-19 Treatment Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific Covid-19 Treatment Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America Covid-19 Treatment Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America Covid-19 Treatment Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa Covid-19 Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa Covid-19 Treatment Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa Covid-19 Treatment Market Size by Country (US$ Million), 2027–2032
 Table 48. Cadila Healthcare Company Details
 Table 49. Cadila Healthcare Business Overview
 Table 50. Cadila Healthcare Covid-19 Treatment Product
 Table 51. Cadila Healthcare Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 52. Cadila Healthcare Recent Development
 Table 53. Johnson & Johnson Company Details
 Table 54. Johnson & Johnson Business Overview
 Table 55. Johnson & Johnson Covid-19 Treatment Product
 Table 56. Johnson & Johnson Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 57. Johnson & Johnson Recent Development
 Table 58. ImmunoPrecise Company Details
 Table 59. ImmunoPrecise Business Overview
 Table 60. ImmunoPrecise Covid-19 Treatment Product
 Table 61. ImmunoPrecise Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 62. ImmunoPrecise Recent Development
 Table 63. Novartis Company Details
 Table 64. Novartis Business Overview
 Table 65. Novartis Covid-19 Treatment Product
 Table 66. Novartis Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 67. Novartis Recent Development
 Table 68. AstraZeneca Company Details
 Table 69. AstraZeneca Business Overview
 Table 70. AstraZeneca Covid-19 Treatment Product
 Table 71. AstraZeneca Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 72. AstraZeneca Recent Development
 Table 73. Cipla Company Details
 Table 74. Cipla Business Overview
 Table 75. Cipla Covid-19 Treatment Product
 Table 76. Cipla Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 77. Cipla Recent Development
 Table 78. AbbVie Company Details
 Table 79. AbbVie Business Overview
 Table 80. AbbVie Covid-19 Treatment Product
 Table 81. AbbVie Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 82. AbbVie Recent Development
 Table 83. Bayer Company Details
 Table 84. Bayer Business Overview
 Table 85. Bayer Covid-19 Treatment Product
 Table 86. Bayer Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 87. Bayer Recent Development
 Table 88. Regeneron Pharmaceuticals Company Details
 Table 89. Regeneron Pharmaceuticals Business Overview
 Table 90. Regeneron Pharmaceuticals Covid-19 Treatment Product
 Table 91. Regeneron Pharmaceuticals Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 92. Regeneron Pharmaceuticals Recent Development
 Table 93. Ascletis Pharma Company Details
 Table 94. Ascletis Pharma Business Overview
 Table 95. Ascletis Pharma Covid-19 Treatment Product
 Table 96. Ascletis Pharma Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 97. Ascletis Pharma Recent Development
 Table 98. GlaxoSmithKline Company Details
 Table 99. GlaxoSmithKline Business Overview
 Table 100. GlaxoSmithKline Covid-19 Treatment Product
 Table 101. GlaxoSmithKline Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 102. GlaxoSmithKline Recent Development
 Table 103. Gilead Sciences Company Details
 Table 104. Gilead Sciences Business Overview
 Table 105. Gilead Sciences Covid-19 Treatment Product
 Table 106. Gilead Sciences Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 107. Gilead Sciences Recent Development
 Table 108. Pharmstandard Company Details
 Table 109. Pharmstandard Business Overview
 Table 110. Pharmstandard Covid-19 Treatment Product
 Table 111. Pharmstandard Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 112. Pharmstandard Recent Development
 Table 113. Fujifilm Holdings Company Details
 Table 114. Fujifilm Holdings Business Overview
 Table 115. Fujifilm Holdings Covid-19 Treatment Product
 Table 116. Fujifilm Holdings Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 117. Fujifilm Holdings Recent Development
 Table 118. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
 Table 119. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview
 Table 120. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Treatment Product
 Table 121. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 122. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
 Table 123. Roche Company Details
 Table 124. Roche Business Overview
 Table 125. Roche Covid-19 Treatment Product
 Table 126. Roche Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 127. Roche Recent Development
 Table 128. Sanofi Company Details
 Table 129. Sanofi Business Overview
 Table 130. Sanofi Covid-19 Treatment Product
 Table 131. Sanofi Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 132. Sanofi Recent Development
 Table 133. Pfizer Company Details
 Table 134. Pfizer Business Overview
 Table 135. Pfizer Covid-19 Treatment Product
 Table 136. Pfizer Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 137. Pfizer Recent Development
 Table 138. Eli Lilly Company Details
 Table 139. Eli Lilly Business Overview
 Table 140. Eli Lilly Covid-19 Treatment Product
 Table 141. Eli Lilly Revenue in Covid-19 Treatment Business (US$ Million), 2021–2026
 Table 142. Eli Lilly Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Covid-19 Treatment Picture
 Figure 2. Global Covid-19 Treatment Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Covid-19 Treatment Market Share by Type: 2025 vs 2032
 Figure 4. Life Support Features
 Figure 5. Antiviral Medicine Features
 Figure 6. Antibody Treatments Features
 Figure 7. Others Features
 Figure 8. Global Covid-19 Treatment Market Size by End User (US$ Million), 2021–2032
 Figure 9. Global Covid-19 Treatment Market Share by End User: 2025 vs 2032
 Figure 10. Children Case Studies
 Figure 11. Adult Case Studies
 Figure 12. Covid-19 Treatment Report Years Considered
 Figure 13. Global Covid-19 Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global Covid-19 Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Covid-19 Treatment Market Share by Region: 2025 vs 2032
 Figure 16. Global Covid-19 Treatment Market Share by Players in 2025
 Figure 17. Global Covid-19 Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by Covid-19 Treatment Revenue in 2025
 Figure 19. North America Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America Covid-19 Treatment Market Share by Country (2021–2032)
 Figure 21. United States Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Covid-19 Treatment Market Share by Country (2021–2032)
 Figure 25. Germany Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Covid-19 Treatment Market Share by Region (2021–2032)
 Figure 33. China Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Covid-19 Treatment Market Share by Country (2021–2032)
 Figure 41. Mexico Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Covid-19 Treatment Market Share by Country (2021–2032)
 Figure 45. Israel Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE Covid-19 Treatment Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Cadila Healthcare Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 49. Johnson & Johnson Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 50. ImmunoPrecise Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 51. Novartis Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 52. AstraZeneca Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 53. Cipla Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 54. AbbVie Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 55. Bayer Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 56. Regeneron Pharmaceuticals Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 57. Ascletis Pharma Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 58. GlaxoSmithKline Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 59. Gilead Sciences Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 60. Pharmstandard Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 61. Fujifilm Holdings Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 62. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 63. Roche Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 64. Sanofi Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 65. Pfizer Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 66. Eli Lilly Revenue Growth Rate in Covid-19 Treatment Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Oral Antiviral Medications for COVID 19 Market Research Report 2025
Covid 19 Treatment Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Treatment for Covid 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Approved COVID 19 Vaccines Market Research Report 2025
Chinese Materia Medica for COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biologic Medication in COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dexamethasone for COVID 19 Market Research Report 2024
COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Medicine Market Research Report 2024
Specific Antiviral Drugs for COVID 19 Market
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemical Medication in COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral COVID 19 Drug Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions